Gamida Cell Operating Income

Gamida Cell (GMDA) currently reports a operating income of $-33M as of March 2024. That compares with $75M in the prior-year period — down 144.3% year over year. Use the charts on this page to explore Gamida Cell's operating income history and peer comparisons.

Gamida Cell's operating income decreased from $75M to $-33M — a 144.3% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Gamida Cell reported $-33M in operating income as of March 2024. That compares with $75M in the prior-year period — down 144.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-33M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Gamida Cell, and consider following GMDA for alerts when major investors trade the stock.

Gamida Cell is classified in the Healthcare sector. On operating income, it currently shows $-33M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GMDA with unrelated industries.